These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 21904525)

  • 1. Beyond the dopamine receptor: regulation and roles of serine/threonine protein phosphatases.
    Walaas SI; Hemmings HC; Greengard P; Nairn AC
    Front Neuroanat; 2011; 5():50. PubMed ID: 21904525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARPP-16 Is a Striatal-Enriched Inhibitor of Protein Phosphatase 2A Regulated by Microtubule-Associated Serine/Threonine Kinase 3 (Mast 3 Kinase).
    Andrade EC; Musante V; Horiuchi A; Matsuzaki H; Brody AH; Wu T; Greengard P; Taylor JR; Nairn AC
    J Neurosci; 2017 Mar; 37(10):2709-2722. PubMed ID: 28167675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cAMP-regulated phosphoproteins DARPP-32, ARPP16/19, and RCS modulate striatal signal transduction through protein kinases and phosphatases.
    Christensen KR; Nairn AC
    Adv Pharmacol; 2021; 90():39-65. PubMed ID: 33706938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic acetylcholine M
    Liu L; Huang Y; Huang Q; Zhao Z; Yu J; Wang L
    Neuropharmacology; 2017 May; 117():376-386. PubMed ID: 28257887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism.
    Brown AM; Deutch AY; Colbran RJ
    Eur J Neurosci; 2005 Jul; 22(1):247-56. PubMed ID: 16029214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DARPP-32 40 years later.
    Girault JA; Nairn AC
    Adv Pharmacol; 2021; 90():67-87. PubMed ID: 33706939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DARPP-32 is a robust integrator of dopamine and glutamate signals.
    Fernandez E; Schiappa R; Girault JA; Le Novère N
    PLoS Comput Biol; 2006 Dec; 2(12):e176. PubMed ID: 17194217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum.
    Kötter R
    Prog Neurobiol; 1994 Oct; 44(2):163-96. PubMed ID: 7831476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of DARPP-32 and ARPP-21 in the Emergence of Temporal Constraints on Striatal Calcium and Dopamine Integration.
    Nair AG; Bhalla US; Hellgren Kotaleski J
    PLoS Comput Biol; 2016 Sep; 12(9):e1005080. PubMed ID: 27584878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia.
    Caporaso GL; Bibb JA; Snyder GL; Valle C; Rakhilin S; Fienberg AA; Hemmings HC; Nairn AC; Greengard P
    Neuropharmacology; 2000 Jul; 39(9):1637-44. PubMed ID: 10854908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DARPP-32: an integrator of neurotransmission.
    Svenningsson P; Nishi A; Fisone G; Girault JA; Nairn AC; Greengard P
    Annu Rev Pharmacol Toxicol; 2004; 44():269-96. PubMed ID: 14744247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons.
    Hara M; Fukui R; Hieda E; Kuroiwa M; Bateup HS; Kano T; Greengard P; Nishi A
    J Neurochem; 2010 May; 113(4):1046-59. PubMed ID: 20236221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A.
    Nishi A; Bibb JA; Matsuyama S; Hamada M; Higashi H; Nairn AC; Greengard P
    J Neurochem; 2002 May; 81(4):832-41. PubMed ID: 12065642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of dopamine D1 and D2 signaling by nicotine in neostriatal neurons.
    Hamada M; Higashi H; Nairn AC; Greengard P; Nishi A
    J Neurochem; 2004 Sep; 90(5):1094-103. PubMed ID: 15312165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of DARPP-32 in the actions of drugs of abuse.
    Nairn AC; Svenningsson P; Nishi A; Fisone G; Girault JA; Greengard P
    Neuropharmacology; 2004; 47 Suppl 1():14-23. PubMed ID: 15464122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine- and cAMP-regulated phosphoprotein DARPP-32: phosphorylation of Ser-137 by casein kinase I inhibits dephosphorylation of Thr-34 by calcineurin.
    Desdouits F; Siciliano JC; Greengard P; Girault JA
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2682-5. PubMed ID: 7708705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DARPP-32 mediates the actions of multiple drugs of abuse.
    Svenningsson P; Nairn AC; Greengard P
    AAPS J; 2005 Oct; 7(2):E353-60. PubMed ID: 16353915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated cocaine administration decreases calcineurin (PP2B) but enhances DARPP-32 modulation of sodium currents in rat nucleus accumbens neurons.
    Hu XT; Ford K; White FJ
    Neuropsychopharmacology; 2005 May; 30(5):916-26. PubMed ID: 15726118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine regulates DARPP-32 (dopamine- and cAMP-regulated phosphoprotein of 32 kDa) phosphorylation at multiple sites in neostriatal neurons.
    Hamada M; Hendrick JP; Ryan GR; Kuroiwa M; Higashi H; Tanaka M; Nairn AC; Greengard P; Nishi A
    J Pharmacol Exp Ther; 2005 Nov; 315(2):872-8. PubMed ID: 16040813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons.
    Kuroiwa M; Hamada M; Hieda E; Shuto T; Sotogaku N; Flajolet M; Snyder GL; Hendrick JP; Fienberg A; Nishi A
    Neuropharmacology; 2012 Dec; 63(7):1248-57. PubMed ID: 22971543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.